KYLE SAVAGE: Open Payments
NPI 1508647280 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,504 in 182 payments from 16 companies in 2025. Trend: 2023 $131 · 2024 $1,838 · 2025 $2,504
Food & beverage: $2,504
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 56 | $891 |
| SCILEX PHARMACEUTICALS INC. | 26 | $323 |
| Tonix Medicines, Inc. | 30 | $227 |
| PFIZER INC. | 13 | $216 |
| Currax Pharmaceuticals LLC | 21 | $207 |
| Axsome Therapeutics, Inc. | 9 | $194 |
| Teva Pharmaceuticals USA, Inc. | 13 | $171 |
| Lundbeck LLC | 5 | $93 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| Novo Nordisk Inc | 1 | $24 |
Products named: BOTOX, UBRELVY, ZEMBRACE SYMTOUCH, QULIPTA, NURTEC ODT, ONZETRA XSAIL, Symbravo, ELYXYB - CELECOXIB.
Industry payments across NY — which companies pay providers there.
